Welcome to the eCancerTrials.com National Cancer Clinical Trials Database. When you or a loved one are diagnosed with cancer, knowing every treatment option available is your first step in receiving the most complete care. Your treatment plan may include choosing to participate in a cancer clinical trial. Clinical trials in cancer are research studies designed to evaluate new cancer treatment, management, and prevention options. Clinical trials conducted with cancer patients evaluate the safety and effectiveness of new or modified cancer treatment strategies. New anticancer drugs, unique approaches to surgery and radiation therapy are used as well as various combinations of cancer treatments.

Many medical professionals encourage those diagnosed with cancer to at least consider participating in a clinical trial in addition to other treatment options. Furthermore, many treatment options for cancer patients are only available through clinical trials, making participation in a trial the only way to access certain therapies. So if you are not evaluating potential cancer treatments accessible through the clinical trials process alongside current standard therapies, you're not weighing all of your available options.

Although there is currently no single, comprehensive source of available clinical trials, eCancerTrials.com’s provides information on more than 2,000 clinical trials being conducted by leading cancer researchers from all 50 states. These clinical trials evaluate novel treatment approaches and new cancer drugs in all major cancer types, including breast cancer, colon cancer, prostate cancer, lung cancer, lymphoma, leukemia, and many others.

eCancerTrials.com is a free and confidential cancer clinical trials matching and referral service. This resource is provided to cancer patients and their caregivers by leading cancer information specialists at CancerConsultants.com. Interested patients and their advocates may use this resource to:

• Search—free of charge—for clinical trials applicable to your situation.
• Search without sharing personal information until you find a trial that is appropriate. At this point you can directly call or e-mail the cancer clinic or center conducting the trial. In this manner your privacy is respected and ensured.
• eCancerTrials.com provides interested patients and their family members with additional services to help locate appropriate clinical trials.

Use the search engine below to look for clinical trials, or learn more about clinical trials.

Search by cancer type:

Select a cancer type --------------------------------- Acute Lymphoid Leukemia Acute Myeloid Leukemia Anal Cancer Any Cancer Any Cancer Type Bladder Cancer Blood Disorders Bone Metastasis Brain/Central Nervous System Cancer Breast Cancer Cervical Cancer Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Colorectal Cancer Esophageal Cancer Gastric Cancer Germ Cell Cancer Head & Neck Cancers High Risk Prostate Cancer Hodgkin's Lymphoma Liver Cancer Lymphoma Malignant Melanoma Malignant Mesothelioma Merkel Cell Cancer Multiple Myeloma Myelodysplastic Syndromes Neuroblastoma Non Small Cell Lung Cancer Non-Hodgkin's Lymphoma - High Grade Non-Hodgkin's Lymphoma - Intermediate Grade Non-Hodgkin's Lymphoma - Low Grade Non-Hodgkin's Lymphoma - Mantle Cell Osteosarcoma Other Ovarian Cancer Pancreatic Cancer Prostate Cancer Renal Cell (Kidney) Cancer Retinoblastoma Rhabdomyosarcoma Sarcoma Skin Cancer Small Cell Lung Cancer Soft Tissue Sarcoma Solid Tumors Supportive Care (Side Effects) Testicular Cancer-Non-Seminoma Testicular Cancer-Seminoma Thymic Thyroid Cancer Unknown Primary Uterine (Endometrial) Cancer Vaginal Cancer Wilm's Tumor  

Filter by:

All cancer stages --------------------------------- Screening & Prevention Stage 1-3 Stage 4 Recurrent/Refractory All States ------------------------------- Northeast Region Southeast Region Midwest Region Northwest Region Southwest Region ------------------------------- Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucy Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Displaying clinical trials in "Ovarian Cancer" in "All cancer stages" in "All States":

Protocol No.	Title
INST0708C	Biological Study: Assessment of Genetic Alterations in the Signaling Network as Prognostic Markers in Ovarian Cancer
REFMAL30-OV	A PHASE I, OPEN-LABEL, MULTI-DOSE, DOSE-ESCALATION STUDY OF GW572016 IN PATIENTS WITH SOLID TUMORS-OV
OVA-GY-17(B)	A Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of Intravenous OvaRex Mab-B43.13 as Post Chemotherapy Consolidation for Epithelial Carcinoma of Ovarian, Tubal or Peritoneal Origin
REFMAL39	A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
GOG-0218	Phase III Trial of Carboplatin and Paclitaxel Plus Placebo versus Carboplatin and Paclitaxel Plus Concurrent Bevacizumab followed by Placebo, versus Carboplatin and Paclitaxel Plus Concurrent and Extended Bevacizumab, in Women with Newly Diagnosed, Previously Untreated, Suboptimal Advanced Stage Epithelial Ovarian and Primary Peritoneal Cancer
GOG0212	GOG 0212, A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND# 70177), Versus No Treatment Until Documented Relapse in Women with Advanced Ovarian or Primary Peritoneal Cancer Who Achieve A Complete Clinical Response to Primary Platinum/Taxane Chemotherapy.
GOG0252	GOG 0252: A Phase III Clinical Trial of Bevacizumab with IV versus IP Chemotherapy in Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma (BEVACIZUMAB NSC #704865, IND #7921)
GOG0190	An Exploratory Evaluation of Fenretinide (4-HPP) as a Chemopreventive Agent for Ovarian Carcinoma.
GIOV-001	Actimmune® (Interferon gamma-1b) in Combination With Chemotherapy (Carboplatin/Paclitaxel) for First-Line Therapy of Advanced Ovarian or Primary Peritoneal Carcinoma
REFMAL31	A STUDY TO DETERMINE THE BIOEQUIVALENCE OF AN ORAL FORMULATION OF TOPOTECAN CONTAINING THE DRUG SUBSTANCE MANUFACTURED BY NEW PROCESS RELATIVE TO THE CURRENT STUDY FORMULATION OF TOPOTECAN IN PATIENTS WITH ADVANCED SOLID TUMORS
REFMAL32	AN OPEN-LABEL, SAFETY, PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF MULTIPLE DOSES OF GW572016 TO EXAMINE THE INHIBITION OF EGFR/ERBB-2 PHOSPHORYLATION IN CANCER PATIENTS WITH SOLID TUMORS
REFMAL33	A PHASE I TRIAL OF WEEKLY AMONAFIDE (AMF)IN PATIENTS WITH ADVANCED, SOLID TUMORS
REFMAL34	A PHASE I STUDY OF TOPOTECAN IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS
DUMC03	A Multicenter, Randomized, Comparative Study to Compare the Efficacy and Safety of Taxotere/Carboplatin Combination Therapy Versus Sequential Therapy with Taxotere then Carboplatin as second-Line treatment of Patients with Relapsed Platinum-Sensitive Ovarian Cancer.
AVF3911s	Phase II and Pharmacokinetic Study of Bevacizumab and Doxil in the Treatment of Platinum-Resistant or Refractory Ovarian Cancer.
CEP0906A2303	A randomized, parallel group, open-label, active controlled, multicenter Phase III trial of Patupilone (EPO906) versus pegylated liposomal doxorubicin (Doxil„µ/Caelyx„µ) in taxene/platinum refractory/resistant patients with recurrent epithelial ovarian, primary fallopian or primary peritoneal cancer.
EMR62206-016	An open-label Phase II study of two dose levels of EMD 273066 administered with low-dose cyclophosphamide following objective response to second-line chemotherapy in women with recurrent ovarian carcinoma.
M10-757	Abbott M10-757: A Phase 2 Randomized Clinical Trial of ABT-888 in Combination with Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Subjects with Recurrent High Grade Serous Ovarian Cancer
GOG0213	A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer
0702C	Role Of HSP70 In Predicting Response Of Patients Diagnosed With Cancer And Treated With Platinum-Based Chemotherapy.